Immunotherapy with Long-Lived Anti-CD20 x Anti-CD3 Bispecific Antibodies Stimulates Potent T Cell-Mediated Killing of Human B Cell Lines and of Circulating and Lymphoid B Cells in Monkeys: A Potential Therapy for B Cell Lymphomas and Leukemias

被引：0
|
作者：
Chu, Seung Y. [1 ]
Lee, Sung-Hyung [1 ]
Rashid, Rumana [1 ]
Chen, Hsing [1 ]
Chan, Emily W. [1 ]
Phung, Sheryl [1 ]
Pong, Erik [1 ]
Endo, Nancy A. [1 ]
Miranda, Yvonne [1 ]
Bonzon, Christine [1 ]
Leung, Irene W. L. [1 ]
Muchhal, Umesh S. [1 ]
Moore, Gregory L. [1 ]
Bernett, Matthew J. [1 ]
Szymkowski, David E. [1 ]
Desjarlais, John R. [1 ]
机构：
[1] Xencor Inc, Monrovia, CA USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Rituximab (anti-CD20) therapy of B-cell lymphomas:: Direct complement killing is superior to cellular effector mechanisms
    Harjunpää, A
    Junnikkala, S
    Meri, S
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2000, 51 (06) : 634 - 641
  • [32] b Relapsed and refractory malignant B cell diseases: Evidence for therapeutic efficacy via subcutaneous administration of anti-CD20 x anti-CD3 antibody lymphomun
    Buhmann, R.
    Ruf, P.
    Hess, J.
    Lindhofer, H.
    Jacob, U.
    Dreyling, M.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S505 - S505
  • [33] Characterization of anti-CD79b/CD3 bispecific antibody, a potential therapy for B cell malignancies
    Wang, Jie
    Li, Chen
    He, Kaijie
    Kuang, Zhihui
    Lu, Jia
    Yao, Ying
    He, Fufan
    Li, Ninghuan
    Li, Li
    Fu, Fenggen
    Wu, Zhihai
    Zhou, Shuaixiang
    Kang, Dian
    Qiu, Xuan
    Wu, Min
    Liu, Yang
    Cao, Xiaochao
    Xu, Mengqiu
    Chen, Bingliang
    Wu, Weiwei
    Guo, Feng
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (02) : 493 - 507
  • [34] Preclinical pharmacology and toxicology of humanized anti-B-cell antibodies (anti-CD22 and anti-CD20) in cynomolgus monkeys (CM).
    Sapra, P
    Kikuchi, G
    Venkatasamy, A
    Hayes, MK
    Satterwhite, CM
    Warren, D
    Walker, MD
    Goldenberg, DM
    Horak, ID
    BLOOD, 2005, 106 (11) : 424A - 424A
  • [35] Characterization of anti-CD79b/CD3 bispecific antibody, a potential therapy for B cell malignancies
    Jie Wang
    Chen Li
    Kaijie He
    Zhihui Kuang
    Jia Lu
    Ying Yao
    Fufan He
    Ninghuan Li
    Li Li
    Fenggen Fu
    Zhihai Wu
    Shuaixiang Zhou
    Dian Kang
    Xuan Qiu
    Min Wu
    Yang Liu
    Xiaochao Cao
    Mengqiu Xu
    Bingliang Chen
    Weiwei Wu
    Feng Guo
    Cancer Immunology, Immunotherapy, 2023, 72 : 493 - 507
  • [36] TRANSLATIONAL FINDINGS FOR REGN1979, A HUMAN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY: FROM PRECLINICAL TO FIRST-IN-HUMAN STUDY IN PATIENTS WITH CD20+B-CELL MALIGNANCIES.
    Zhu, M.
    Smith, E.
    Kirshner, J.
    Toroghi, M.
    Davis, J.
    Di-Cioccio, A.
    Retter, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S103 - S103
  • [37] Phase 1 Study of REGN1979, an Anti-CD20 x Anti-CD3 Bispecific Monoclonal Antibody, in Patients with CD20+B-Cell Malignancies Previously Treated with CD20-Directed Antibody Therapy
    Bannerji, Rajat
    Brown, Jennifer R.
    Advani, Ranjana H.
    Arnason, Jon
    O'Brien, Susan M.
    Allan, John N.
    Chavez, Julio C.
    Barnes, Jeffrey A.
    Joyce, Robin
    Ansell, Stephen
    Topp, Max S.
    Adriaens, Lieve
    Ufkin, Melanie
    Kostic, Ana
    Paccaly, Anne
    Gao, Bo
    Trail, Pamela A.
    Lowy, Israel
    Brownstein, Carrie
    BLOOD, 2016, 128 (22)
  • [38] Bi20 (FBTA05), a novel trifunctional bispecific antibody (anti-CD20 x anti-CD3), mediates efficient killing of B-cell lymphoma cells even with very low CD20 expression levels
    Stanglmaier, Michael
    Faltin, Margot
    Ruf, Peter
    Bodenhausen, Annette
    Schroeder, Petra
    Lindhofer, Horst
    INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (05) : 1181 - 1189
  • [39] Construction and Characterization of a Bispecific Anti-CD20 Antibody with Potent Antitumor Activity against B-Cell Lymphoma
    Li, Bohua
    Zhang, Xunming
    Shi, Shu
    Zhao, Lei
    Zhang, Dapeng
    Qian, Weizhu
    Zheng, Lei
    Gao, Jie
    Wang, Hao
    Guo, Yajun
    CANCER RESEARCH, 2010, 70 (15) : 6293 - 6302
  • [40] Costimulation with agonistic anti-CD28 antibodies prevents T cell apoptosis and is required for efficient immunotherapy with CD3x19 bispecific antibodies in B cell lymphoma
    Daniel, PT
    Kroidl, A
    Pezzutto, A
    Moldenhauer, G
    Dorken, B
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 97 - 97
12345